Antivirals play their part in reshaping the viral diagnostics market
This article was originally published in Clinica
Executive Summary
Antiviral drugs to treat HIV, HCV and HBV will be key drivers of the in vitro diagnostics market in the years ahead, says a new publication from Clinica